OK I'll stop after this but since the letter to
Post# of 151120
(Total Views: 429)
Posted On: 03/20/2025 12:19:29 PM
OK I'll stop after this but since the letter to shareholders mentioned a Leronlimab/ stroke trial, here's an article related to that.
Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke.
https://www.otcmarkets.com/stock/CYDY/news/Le...?id=277935
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼